The fundamental demand outlook for the mining and metals sector is strong coming into 2013, but cost competitiveness and project execution remain the focus for global mining and metals companies.
Loss of sales due to non-availability of products in the pharma distribution setup and lack of visibility of pharma companies into stock holding and stock movement in the supply chain were identified as key concern areas, according to our latest study Unlocking the potential of the pharma distribution channel.
Ernst & Young announced global revenues of US$24.4 billion for the financial year ended 30 June 2012, compared with US$22.9 billion in 2011, a 7.6% increase.
Views
Contact us
Have questions about a specific Ernst & Young service? Whatever your inquiry, we'll help direct you to the right place.
